Aurelian Life Sciences · 13 hours ago
Biopharma-Head of Finance
United States
Full-time
Remote
Director/Executive
8+ years expAurelian Life Sciences is a specialized asset development and commercialization platform focused on advancing clinically validated therapies into the U.S. market. They are seeking an Executive Financial Partner / Head of Finance to lead the firm’s financial strategy across the holding company and its portfolio of asset subsidiaries.
Biotechnology
Responsibilities
Design and oversee financial structures across asset-level subsidiaries and the holding company
Define and manage capital flows between development partners, asset subsidiaries, and Aurelian HoldCo
Establish and govern financial frameworks supporting asset advancement and strategic outcomes
Build and oversee asset-level and portfolio-level financial models covering development costs, milestones, commercialization ramp, and monetization scenarios
Implement governance, reporting, and control frameworks appropriate for multi-entity operations
Manage portfolio-wide financial planning across assets with staggered timelines and risk profiles
Serve as the primary financial counterpart to capital partners and development partners
Support diligence processes, negotiations, and execution of complex transactions
Translate clinical, regulatory, and commercial milestones into clear financial narratives
Advise on asset selection, sequencing, and capital allocation
Partner with leadership on long-term platform strategy, scalability, and capital recycling
Contribute to decisions around timing and structure of asset monetization events
Qualification
Required
8+ years of senior experience in biopharma finance, structured finance, healthcare investing, or asset-focused operating roles
Demonstrated experience managing complex financial structures involving multiple stakeholders and entities
Strong understanding of drug development economics and early commercialization dynamics
Experience operating in lean, high-accountability environments
Strategic mindset with the ability to balance precision, flexibility, and speed
Benefits
Deferred compensation tied to pre-capital and structuring activities
Post-transaction cash compensation
Equity in holding company & carried interest in assets bridged.
Company
Aurelian Life Sciences
Aurelian Life Sciences LLC is a dedicated bridge for innovative therapies, acquiring rights to strong candidates in hematology/oncology and rare diseases that demonstrate significant potential for patient impact.
2-10 employees
Funding
Current Stage
Early StageCompany data provided by crunchbase